3D bioprinted porous PLLA implants with dual gene modified BMSCs for osteoarthritis cartilage repair
Acta Orthopaedica Belgica · 2026
DOI: 10.52628/92.3.15544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Orthopaedica Belgica, 2026. Verfasst von T Liu und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Osteoarthritis, Printing, Three-Dimensional, Bioprinting.
Abstract (Originalsprache)
This study evaluated whether three-dimensional (3D) bioprinted spherical, porous poly-L-lactic acid (PLLA) drug- loaded implants, combined with bone marrow mesenchymal stem cells (BMSCs) overexpressing transforming growth factor-β1 (TGF-β1) and interleukin-10 (IL-10), can enhance the repair of osteoarthritis (OA)-related cartilage defects. Rat BMSCs were transduced with lentiviral vectors to achieve dual overexpression of TGF-β1 and IL-10, induced toward chondrogenic differentiation, and assessed for chondrogenic marker expression (COL2A1, SOX-9, and aggrecan). Spherical porous PLLA drug-loaded implants were fabricated by 3D bioprinting and characterized for drug loading, porosity, cytocompatibility, skin sensitization, biodegradation, and in vivo release behavior. Histology, micro-computed tomography (micro-CT), and molecular assays evaluated cartilage repair and subchondral bone remodeling. Dual-gene transduction markedly promoted BMSC chondrogenic differentiation with significant up-regulation of COL2A1, SOX-9, and aggrecan. The PLLA scaffolds exhibited high porosity (88.88 ± 2.87%), meeting biomaterial requirements, showed no evident cytotoxicity or skin sensitization, and achieved a 12-week mass-loss (biodegradation) of 42.65%. In vivo, the combined treatment group displayed superior cartilage regeneration and subchondral bone repair compared with controls, accompanied by increased BMP2 and type II collagen (COL-2) expression. 3D-bioprinted porous PLLA drug-loaded implants combined with TGF-β1/IL-10 dual-gene-transduced BMSCs effectively promote repair of OA cartilage defects, indicating satisfactory biocompatibility and potential for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Liu, T., Zhang, S., Wang, B., Mei, Z., Xiao, G., He, H., Zhao, Y., Wu, S. Y., Yang, Z., DU, K., & Liu, P. (2026). 3D bioprinted porous PLLA implants with dual gene modified BMSCs for osteoarthritis cartilage repair. Acta Orthopaedica Belgica. https://doi.org/10.52628/92.3.15544
Vancouver
Liu T, Zhang S, Wang B, Mei Z, Xiao G, He H, et al. 3D bioprinted porous PLLA implants with dual gene modified BMSCs for osteoarthritis cartilage repair. Acta Orthopaedica Belgica. 2026. doi:10.52628/92.3.15544
BibTeX
@article{Liu2026,
author = {Liu, T and Zhang, S and Wang, B and Mei, Z and Xiao, G and He, H and Zhao, Y and Wu, S-Y and Yang, Z and DU, K and Liu, P},
title = {3D bioprinted porous PLLA implants with dual gene modified BMSCs for osteoarthritis cartilage repair},
journal = {Acta Orthopaedica Belgica},
year = {2026},
doi = {10.52628/92.3.15544}
}
EUVIMED